The Russian Direct Investment Fund announces the registration of the Russian Sputnik V vaccine against coronavirus by the State Agency for Medicines and Health Technologies (Agencia Estatal De Medicamentos Y Tecnologías En Salud, AGEMED) of the Plurinational State of Bolivia, PRNewswire informs.
The vaccine was registered under the emergency use authorization procedure and was approved by AGEMED based on the results of Phase III clinical trials in Russia, without additional trials in Bolivia. Sputnik V was registered by Argentina's regulator ANMAT under the same procedure on December 23, 2020.
According to PRNewswire, phase III clinical trial data obtained in Russia was also accepted by regulators in Serbia and Belarus to register Sputnik V and begin the vaccination of the population. In Serbia, the vaccination started on January 6, 2021, and in Belarus – on December 29, 2020.
